UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000036743
Receipt No. R000041868
Scientific Title Phase II study of image-guided proton therapy for solitary primary hepatocellular carcinoma with indication for standard treatment
Date of disclosure of the study information 2019/05/20
Last modified on 2019/05/14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Phase II study of image-guided proton therapy for solitary primary hepatocellular carcinoma with indication for standard treatment
Acronym Phase II study of image-guided proton therapy for solitary primary hepatocellular carcinoma with indication for standard treatment
Scientific Title Phase II study of image-guided proton therapy for solitary primary hepatocellular carcinoma with indication for standard treatment
Scientific Title:Acronym Phase II study of image-guided proton therapy for solitary primary hepatocellular carcinoma with indication for standard treatment
Region
Japan

Condition
Condition solitary primary hepatocellular carcinoma
Classification by specialty
Hepato-biliary-pancreatic medicine Hepato-biliary-pancreatic surgery Radiology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate the efficacy and safety of image-guided proton therapy for solitary primary hepatocellular carcinoma that was amenable to standard treatment (resection or ablation)
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes 2-year overall survival
Key secondary outcomes local control rate, progression free survival,response rate,incidence of grade 3 or higher adverse events,change of quality of life (QOL)

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Other
Interventions/Control_1 image-guided proton therapy
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >=
Gender Male and Female
Key inclusion criteria 1) histologically-confirmed or image-diagnosed solitary primary HCC staged as T1N0M0 (UICC TNM 7th ed.)
2) no history of previous HCC
3) patient refusal of surgery or radiofrequency ablation
4) no previous radiotherapy around the lesion
5) age: 20-80 years old
6) ECOG-PS: 0-1
7) Child-Pugh classification A5, 6 or B7
8) dose constraints of the organs at risk achievable
9) tumor diameter < 12 cm
10) written informed consent
Key exclusion criteria 1)pregnancy or lactation
2)severe psychological disorders
3)active and uncontrolled infection
4)Other cancers within 5 years
5)continuous systemic administration (oral or intravenous) of steroids
6)esophageal varix at high risk of bleeding (F3, Rc ++ or higher)
7)portal vein tumor thrombosis
8)cases in which the doctor is judged inappropriate for medical, psychological or other reasons other than the above
Target sample size 45

Research contact person
Name of lead principal investigator
1st name Hiroyuki
Middle name
Last name Ogino
Organization Nagoya City West Medical Center,Nagoya Proton Therapy Center
Division name Radiation oncology
Zip code 462-8508
Address 1-1-1 Hirate-cho, Kita-ku, Nagoya-city, Aichi-prefecture
TEL 052-991-8577
Email oginogio@gmail.com

Public contact
Name of contact person
1st name Hiromitsu
Middle name
Last name Iwata
Organization Nagoya City West Medical Center,Nagoya Proton Therapy Center
Division name Radiation oncology
Zip code 462-8508
Address 1-1-1 Hirate-cho, Kita-ku, Nagoya-city, Aichi-prefecture
TEL 052-991-8577
Homepage URL
Email h-iwa-ncu@nifty.com

Sponsor
Institute Nagoya City West Medical Center
Institute
Department

Funding Source
Organization Nagoya City West Medical Center,Nagoya Proton Therapy Center
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Clinical Study Committees of the Nagoya City Hospital
Address 1-2-23 Wakamizu, Chikusa-ku, Nagoya-city, Aichi-prefecture
Tel 052-721-7171
Email rinsho1@higashi-hosp.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 05 Month 20 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 45
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2013 Year 03 Month 28 Day
Date of IRB
2013 Year 03 Month 19 Day
Anticipated trial start date
2013 Year 06 Month 15 Day
Last follow-up date
2019 Year 09 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2019 Year 05 Month 14 Day
Last modified on
2019 Year 05 Month 14 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041868

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.